Cart
sales@molnova.com
AJM300
CAS No. 401905-67-7
AJM300 ( AJM 300;AJM-300 )
Catalog No. M14377 CAS No. 401905-67-7
AJM300 (AJM 300, AJM-300) is a novel potent, selective, oraaly available alpha 4 integrin antagonist fortreatment of active ulcerative colitis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 170 | Get Quote |
|
| 10MG | 282 | Get Quote |
|
| 25MG | 560 | Get Quote |
|
| 50MG | 860 | Get Quote |
|
| 100MG | 1251 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAJM300
-
NoteResearch use only, not for human use.
-
Brief DescriptionAJM300 (AJM 300, AJM-300) is a novel potent, selective, oraaly available alpha 4 integrin antagonist fortreatment of active ulcerative colitis.
-
DescriptionAJM300 (AJM 300, AJM-300) is a novel potent, selective, oraaly available alpha 4 integrin antagonist fortreatment of active ulcerative colitis.Other Indication Phase 3 Clinical
-
SynonymsAJM 300;AJM-300
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIntegrin
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number401905-67-7
-
Formula Weight569.44
-
Molecular FormulaC28H26Cl2N4O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OC)[C@H](CC1=CC=C(N2C(N(C)C3=C(C=C(N(C)C)C=C3)C2=O)=O)C=C1)NC(C4=C(Cl)C=CC=C4Cl)=O
-
Chemical Namemethyl (S)-2-(2,6-dichlorobenzamido)-3-(4-(6-(dimethylamino)-1-methyl-2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)phenyl)propanoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Halland N, et al. ACS Med Chem Lett. 2014 Jan 10;5(2):193-8.
2. Park SC, et al. World J Gastroenterol. 2018 May 7;24(17):1868-1880.
3. Sugiura T, et al. J Crohns Colitis. 2013 Dec;7(11):e533-42.
4. Yoshimura N, et al. Gastroenterology. 2015 Dec;149(7):1775-1783.e2.
2. Park SC, et al. World J Gastroenterol. 2018 May 7;24(17):1868-1880.
3. Sugiura T, et al. J Crohns Colitis. 2013 Dec;7(11):e533-42.
4. Yoshimura N, et al. Gastroenterology. 2015 Dec;149(7):1775-1783.e2.
molnova catalog
related products
-
Echistatin, α1 isofo...
Potent irreversible αVβ3 integrin antagonist (Ki = 0.27 nM). Disrupts attachment of osteoclasts to bone and inhibits bone reabsorption (IC50 = 0.1 nM). Prevents ADP-induced platelet aggregation via inhibition of glycoprotein IIb/IIIa (GpIIb/IIIa, αIIbβ3) receptors (IC50 = 30 nM) in vitro.
-
RGD peptide GRGDNP
RGD peptide (GRGDNP) acts as an inhibitor of integrin-ligand interactions and can induce apoptosis in the absence of signals and integrin-mediated cell clustering.
-
α2β1 integrin-IN-15
α2β1 integrin-IN-15 highly potent, selective, allosteric small-molecule inhibitor of integrin α2β1 with IC50 of 12 nM.
